UIP

Managing the transition to central bank digital currency

Retrieved on: 
Wednesday, February 14, 2024

Key Points: 

    Koppers Announces Leadership Transition Plan

    Retrieved on: 
    Thursday, January 4, 2024

    PITTSBURGH, Jan. 4, 2024 /PRNewswire/ -- Koppers Inc., a wholly-owned subsidiary of Koppers Holdings Inc. (NYSE: KOP), today announced a transition plan that will occur throughout 2024 for key leadership roles. The plan will culminate in the retirement of James Healey, Vice President, Utility and Industrial Products (UIP), effective December 31, 2024, after a 40-year career with the company. Mr. Healey will serve as Special Assistant to the President and COO effective July 1, 2024, and remain actively involved in the UIP leadership transition for the remainder of the year.

    Key Points: 
    • James Healey, Vice President, Utility and Industrial Products, to Retire at Year-End 2024,
      Jason Bakk Named Successor for Vice President, Utility and Industrial Products,
      Brett Johnston Named Successor for Vice President,
      PITTSBURGH, Jan. 4, 2024 /PRNewswire/ -- Koppers Inc., a wholly-owned subsidiary of Koppers Holdings Inc. (NYSE: KOP), today announced a transition plan that will occur throughout 2024 for key leadership roles.
    • Mr. Healey will serve as Special Assistant to the President and COO effective July 1, 2024, and remain actively involved in the UIP leadership transition for the remainder of the year.
    • Regarding his retirement, Mr. Healey said, "It has been my privilege to have made my entire career at Koppers.
    • As this transition gets under way, we have every confidence that Jason and Brett will succeed in their new roles.

    Unisys Opens Registration for Its 15th Annual Unisys Innovation Program

    Retrieved on: 
    Wednesday, October 18, 2023

    BENGALURU, India, and BLUE BELL, Pa., Oct. 18, 2023 /PRNewswire/ -- Unisys (NYSE: UIS) has opened registration for its fifteenth annual Unisys Innovation Program (UIP), the company's flagship technical project competition for engineering students in India. The ten-month program provides a platform for budding innovators to learn hands-on from Unisys mentors, subject matter experts and other leaders before entering the workforce. This experience is designed to push participants to think creatively and develop cutting-edge technologies that have the potential to make a significant impact on organizations in various industries.

    Key Points: 
    • The ten-month program provides a platform for budding innovators to learn hands-on from Unisys mentors, subject matter experts and other leaders before entering the workforce.
    • Once they have chosen their theme, participants can apply their creativity, problem-solving skills, technical expertise and teamwork as they navigate various stages of the program.
    • "Our Unisys Innovation Program is focused on equipping the participants with the specialized technical skills of the future and enhancing their employability across the globe."
    • To learn more about the Unisys Innovation Program and submission process, click here .

    New Data Presented at CHEST 2023 Demonstrate the Clinical Utility of Veracyte’s Envisia Genomic Classifier for Patients with Interstitial Lung Disease

    Retrieved on: 
    Thursday, October 12, 2023

    (Nasdaq: VCYT) today announced that new data presented at the American College of Chest Physicians (CHEST) Annual Meeting 2023 demonstrate the clinical utility of the company’s Envisia Genomic Classifier, which is used by physicians to improve diagnostic and prognostic confidence of interstitial lung diseases (ILDs).

    Key Points: 
    • (Nasdaq: VCYT) today announced that new data presented at the American College of Chest Physicians (CHEST) Annual Meeting 2023 demonstrate the clinical utility of the company’s Envisia Genomic Classifier, which is used by physicians to improve diagnostic and prognostic confidence of interstitial lung diseases (ILDs).
    • The studies also underscore the challenge of identifying usual interstitial pneumonia (UIP) in patients being evaluated for ILD.
    • The studies presented at the CHEST Annual Meeting show that adding the Envisia Genomic Classifier to the diagnostic process can improve the ability to detect UIP.
    • For patients with indeterminate HRCT results, adding the Envisia Genomic Classifier more than doubled the UIP diagnostic yield to 49%.

    Bristol Myers Squibb’s Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study

    Retrieved on: 
    Saturday, September 9, 2023

    Bristol Myers Squibb (NYSE: BMY) today announced results from a Phase 2 study evaluating BMS-986278, a potential first-in-class, oral, lysophosphatidic acid receptor 1 (LPA1) antagonist in patients with progressive pulmonary fibrosis (PPF).

    Key Points: 
    • Bristol Myers Squibb (NYSE: BMY) today announced results from a Phase 2 study evaluating BMS-986278, a potential first-in-class, oral, lysophosphatidic acid receptor 1 (LPA1) antagonist in patients with progressive pulmonary fibrosis (PPF).
    • The study showed that twice-daily administration of 60 mg of BMS-986278 over 26 weeks reduced the rate of decline in percent predicted forced vital capacity (ppFVC) by 69% compared to placebo (overall, 38% of patients in the study received background antifibrotic therapy).
    • Stable background use of antifibrotics in the IPF cohort and/or select immunosuppressives in the PPF cohort were allowed.
    • The primary endpoint of the study was rate of change in ppFVC from baseline to Week 26 in the IPF cohort.

    ThisWay Global Announces FloCareer as Inaugural UIP Partner

    Retrieved on: 
    Wednesday, August 30, 2023

    AUSTIN, Texas, Aug. 30, 2023 /PRNewswire/ -- ThisWay Global, the leader in AI bias-removal and talent acquisition sourcing technology, announced FloCareer as the inaugural partner of its Universal Integration Platform (UIP), a cloud-based module unveiled last month. UIP streamlines and fast-tracks integration and business automation for most top HR applications in companies of all sizes. UIP enables HR tech vendors to seamlessly integrate their products and services so employers can work with a unified platform to manage their HR tech stack more efficiently.

    Key Points: 
    • AUSTIN, Texas, Aug. 30, 2023 /PRNewswire/ -- ThisWay Global , the leader in AI bias-removal and talent acquisition sourcing technology, announced FloCareer as the inaugural partner of its Universal Integration Platform (UIP), a cloud-based module unveiled last month.
    • Large companies typically integrate, on average, 20 or more core HR systems; ThisWay's UIP dramatically reduces complexity, time, and integration costs.
    • With UIP, ThisWay Global is advancing the ecosystem to enable HR tech solutions to exchange information more synergistically.
    • "We're delighted to welcome FloCareer as our first UIP partner," said Angela Hood, CEO of ThisWay Global.

    ThisWay Global Announces Groundbreaking Universal Integration Platform (UIP) for HR Tech Vendors

    Retrieved on: 
    Thursday, July 20, 2023

    AUSTIN, Texas, July 20, 2023 /PRNewswire/ -- ThisWay Global, the leader in bias removal and talent acquisition sourcing technology, is proud to announce the launch of the eagerly anticipated Universal Integration Platform (UIP). UIP is a cloud-based module of ThisWay Global that enables HR tech vendors to seamlessly integrate their products and services, providing employers with a unified platform to manage their HR tech stack.

    Key Points: 
    • UIP is a cloud-based module of ThisWay Global that enables HR tech vendors to seamlessly integrate their products and services, providing employers with a unified platform to manage their HR tech stack.
    • "UIP is a game-changer for the HR tech industry," said ThisWay Global CEO Angela Hood.
    • Universal Connectivity: Achieve easy and universal access to the most efficient HR tech solutions by connecting them directly through the UIP platform.
    • ThisWay Global's UIP is designed to revolutionize the HR tech industry, creating a unified platform where multiple HR tech solutions can work together seamlessly to streamline workflows and improve communication for HR professionals.

    New Data Presented at ATS 2023 Reinforce Clinical Utility of Veracyte’s Genomic Tests in Interstitial Lung Disease and Lung Cancer

    Retrieved on: 
    Wednesday, May 24, 2023

    Veracyte, Inc. (Nasdaq: VCYT) today announced new data suggesting its novel genomic tests may positively impact diagnosis and care for patients being evaluated for interstitial lung disease (ILD) or lung cancer.

    Key Points: 
    • Veracyte, Inc. (Nasdaq: VCYT) today announced new data suggesting its novel genomic tests may positively impact diagnosis and care for patients being evaluated for interstitial lung disease (ILD) or lung cancer.
    • The findings were presented at ATS 2023, the annual meeting of the American Thoracic Society, which is being held May 21-24 in Washington, D.C.
    • For Veracyte’s Percepta Nasal Swab, researchers presented updated preliminary study findings showing the test’s potential to better stratify the risk of lung cancer for patients with lung nodules.
    • “Importantly, these findings suggest that our tests in interstitial lung disease and lung cancer are performing as intended.”

    Unisys Innovation Program (UIP) Announces This Year's Winners

    Retrieved on: 
    Thursday, May 18, 2023

    BENGALURU, India and BLUE BELL, Pa., May 18, 2023 /PRNewswire/ -- Unisys (NYSE: UIS) announces the winners of the company's annual technical project competition for engineering students in India – the Unisys Innovation Program (UIP). The program's goal is to connect young engineers with today's business leaders to collaborate on new-age tech and innovations.

    Key Points: 
    • BENGALURU, India and BLUE BELL, Pa., May 18, 2023 /PRNewswire/ -- Unisys (NYSE: UIS) announces the winners of the company's annual technical project competition for engineering students in India – the Unisys Innovation Program (UIP).
    • Registration for the program closed in February with more than 7000 registrants.
    • The winners of the 14th Annual Unisys Innovation Program are:
      First place goes to M S Ramaiah Institute of Technology for their project, Sleep Apnea Detection using Personal IoT Devices with Novel Privacy Persevered Federated Learning.
    • "Curiosity and innovation are at the heart of all we do, and the Unisys Innovation Program is one of many platforms we host to stimulate collaborative thinking, experiential learning, and to cultivate a pipeline of promising talent."

    NEC and T-Metrics Combine Industry-Leading Technologies to Provide a Robust and Highly Responsive On-Premises Contact Center Solution

    Retrieved on: 
    Wednesday, January 18, 2023

    IRVING, Texas and CHARLOTTE, N.C., Jan. 18, 2023 /PRNewswire/ -- NEC Corporation of America (NEC), a leading provider and integrator of advanced IT, communications and networking solutions, and T-Metrics, Inc., a provider of next-generation omnichannel contact center systems, today announced a strategic go-to-market alliance that provides organizations maximum control over their ability to deliver seamless contact center experiences across multiple touchpoints within an on-premises business model.

    Key Points: 
    • "Our NEC T-Metrics alliance allows our customers to effortlessly adopt a full-featured premise managed omnichannel contact center solution.
    • By integrating T-Metrics' contact center solution with NEC's UNIVERGE SV9500 communications platform, organizations can take control of their contact centers with a broad set of advanced communications tools and capabilities.
    • NEC and T-Metrics see this as an underserved market, which our joint solution will fill for customers who want to keep their contact center on their premises."
    • It further demonstrates our ability to seamlessly integrate our advanced contact center solution with all major unified communication provider platforms," Pravato said.